BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25942432)

  • 1. A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives.
    Bogaert P; Bochenek T; Prokop A; Pilc A
    PLoS One; 2015; 10(5):e0125691. PubMed ID: 25942432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study.
    Yang C; Wu L; Cai W; Zhu W; Shen Q; Li Z; Fang Y
    PLoS One; 2016; 11(10):e0165183. PubMed ID: 27780218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study.
    De Weerdt E; De Rijdt T; Simoens S; Casteels M; Huys I
    PLoS One; 2017; 12(3):e0174556. PubMed ID: 28350827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the European Union's early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020-2022).
    Ravela R; Airaksinen M; Lyles A
    J Pharm Policy Pract; 2023 Nov; 16(1):135. PubMed ID: 37936250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
    Pauwels K; Huys I; Casteels M; Simoens S
    BMC Health Serv Res; 2014 Sep; 14():438. PubMed ID: 25257912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New regulatory strategies to manage medicines shortages in Europe.
    Musazzi UM; Di Giorgio D; Minghetti P
    Int J Pharm; 2020 Apr; 579():119171. PubMed ID: 32092455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into European drug shortages: a survey of hospital pharmacists.
    Pauwels K; Simoens S; Casteels M; Huys I
    PLoS One; 2015; 10(3):e0119322. PubMed ID: 25775406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug shortages in the hospital: management, causes and budget impact].
    Claus B; Pauwels K; Baert M; Depoorter J; De Weerdt E; Boussery K; De Spiegeleer B; Commeyne S
    J Pharm Belg; 2015 Mar; (1):24-34. PubMed ID: 26571794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug shortages : a fatality ?].
    Goncette V; Radermecker R
    Rev Med Liege; 2024 Jan; 79(1):23-28. PubMed ID: 38223966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug shortages in developed countries--reasons, therapeutic consequences, and handling.
    Dill S; Ahn J
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1405-12. PubMed ID: 25228250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of EAHP's 2019 Medicines Shortages Survey.
    Miljković N; Batista A; Polidori P; Kohl S; Horák P
    Eur J Hosp Pharm; 2020 Jul; 27(4):202-208. PubMed ID: 32471816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new regulatory tools of the 2016 Health Law to fight drug shortages in France.
    Bocquet F; Degrassat-Théas A; Peigné J; Paubel P
    Health Policy; 2017 May; 121(5):471-476. PubMed ID: 28366432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug shortage management: A qualitative assessment of a collaborative approach.
    Chen E; Goold S; Harrison S; Ali I; Makki I; Kent SS; Shuman AG
    PLoS One; 2021; 16(4):e0243870. PubMed ID: 33891609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine shortages in Australia: causes, impact and management strategies in the community setting.
    Tan YX; Moles RJ; Chaar BB
    Int J Clin Pharm; 2016 Oct; 38(5):1133-41. PubMed ID: 27383246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Shortages in Canada and Selected European Countries: A Cross-Sectional, Institution-Level Comparison.
    Videau M; Chemali L; Stucki C; Saavedra-Mitjans M; Largana S; Guerin A; Bonnabry P; Delhauteur B; Van Hees T; Lebel D; Bussières JF
    Can J Hosp Pharm; 2019; 72(1):7-15. PubMed ID: 30828089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland.
    Heiskanen K; Ahonen R; Kanerva R; Karttunen P; Timonen J
    PLoS One; 2017; 12(6):e0179479. PubMed ID: 28658307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public information on shortages in the EU/EEA: improvements made between 2018 and 2020.
    Abed I; Garcia Burgos J; Knudsen Y
    Eur J Hosp Pharm; 2024 Jun; 31(4):344-347. PubMed ID: 36754622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.
    Bochenek T; Abilova V; Alkan A; Asanin B; de Miguel Beriain I; Besovic Z; Vella Bonanno P; Bucsics A; Davidescu M; De Weerdt E; Duborija-Kovacevic N; Fürst J; Gaga M; Gailīte E; Gulbinovič J; Gürpınar EU; Hankó B; Hargaden V; Hotvedt TA; Hoxha I; Huys I; Inotai A; Jakupi A; Jenzer H; Joppi R; Laius O; Lenormand MC; Makridaki D; Malaj A; Margus K; Marković-Peković V; Miljković N; de Miranda JL; Primožič S; Rajinac D; Schwartz DG; Šebesta R; Simoens S; Slaby J; Sović-Brkičić L; Tesar T; Tzimis L; Warmińska E; Godman B
    Front Pharmacol; 2017; 8():942. PubMed ID: 29403372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of health workforce mobility in the European Union under the current supply challenges. SESPAS Report 2024.
    Blanco Moreno A
    Gac Sanit; 2024; 38 Suppl 1():102393. PubMed ID: 38714433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.